triflusal has been researched along with Diabetes Mellitus, Type 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conget, JI; Esmatjes, E; Fernandez, MR; Ferrer, JP; Gaya, J; Rivera, F; Vilardell, E | 1 |
| Conget, I; Coves, MJ; Esmatjes, E; Gállego, M; Maseras, M | 1 |
| De la Cruz, JP; Garcia-Arnes, J; Pavia, J; Sanchez de la Cuesta, F | 1 |
1 trial(s) available for triflusal and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effect of treatment with an inhibitor of platelet aggregation on the evolution of background retinopathy: 2 years of follow-up.
Topics: Adult; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Humans; Male; Platelet Aggregation Inhibitors; Salicylates; Visual Acuity | 1989 |
2 other study(ies) available for triflusal and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effects of thromboxane synthesis inhibitor triflusal on renal hemodynamics in microalbuminuric diabetic patients.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Albuminuria; Blood Glucose; Diabetes Mellitus, Type 1; Dinoprostone; Female; Glomerular Filtration Rate; Humans; Male; Platelet Aggregation Inhibitors; Renal Circulation; Renin; Salicylates; Thromboxane B2 | 1990 |
Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.
Topics: Adult; Aspirin; beta-Thromboglobulin; Diabetes Mellitus, Type 1; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins F; Salicylates; Thromboxane B2 | 1988 |